HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two cesarean deliveries after hemi-hysterectomy due to gestational trophoblastic neoplasia.

AbstractOBJECTIVE:
Although uterine didelphys per se is not associated with an impaired ability to conceive, the association between uterine anomalies and gestational trophoblastic neoplasia (GTN) remains unclear. The management of chemotherapy-resistant GTN in women with uterine didelphys raises a new issue regarding whether to perform a hemi-hysterectomy.
CASE REPORT:
A 23-year-old, gravida 1, para 0 Japanese woman was referred with a failed intermittent cervical dilatation for hematometra. Four years previously, she developed a GTN Stage III, score 5. As two cycles of chemotherapy with methotrexate (MTX) and one cycle of EMA-CO (etoposide, MTX, actinomycin D, cyclophosphamide and vincristine) did not result in remission, we performed an abdominal hemi-hysterectomy. After a canalization procedure and cervicoplasty were performed, the patient conceived naturally and prematurely delivered by cesarean section twice.
CONCLUSION:
A hemi-hysterectomy should be considered for fertility preservation when GTN develops on either side of a didelphic uterus and adjuvant chemotherapy does not result in remission.
AuthorsKentaro Kai, Yasushi Kawano, Mitsutake Yano, Mamiko Okamoto, Eiichi Hori, Kaei Nasu, Hisashi Narahara
JournalTaiwanese journal of obstetrics & gynecology (Taiwan J Obstet Gynecol) Vol. 57 Issue 2 Pg. 315-318 (Apr 2018) ISSN: 1875-6263 [Electronic] China (Republic : 1949- )
PMID29673680 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2018. Published by Elsevier B.V.
Topics
  • Adult
  • Cesarean Section
  • Chemotherapy, Adjuvant
  • Female
  • Gestational Age
  • Gestational Trophoblastic Disease (drug therapy, pathology, surgery)
  • Humans
  • Hysterectomy (methods)
  • Male
  • Pregnancy
  • Premature Birth
  • Uterus (abnormalities, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: